If you made any changes in Pure these will be visible here soon.

Research Output

2020

Bariatric surgery and kidney disease outcomes in severely obese youth: Bariatric surgery and kidney disease

Bjornstad, P., Nehus, E. & van Raalte, D., Feb 2020, In : Seminars in Pediatric Surgery. 29, 1, 150883.

Research output: Contribution to journalArticleAcademicpeer-review

Gut microbiota: a promising target against cardiometabolic diseases

Warmbrunn, M. V., Herrema, H., Aron-Wisnewsky, J., Soeters, M. R., Van Raalte, D. H. & Nieuwdorp, M., 1 Jan 2020, In : Expert review of endocrinology & metabolism. 15, 1, p. 13-27 15 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Insulin Sensitivity and Renal Hemodynamic Function in Metformin-Treated Adults With Type 2 Diabetes and Preserved Renal Function

van Bommel, E. J. M., Ruiter, D., Muskiet, M. H. A., van Baar, M. J. B., Kramer, M. H. H., Nieuwdorp, M., Joles, J. A., Bjornstad, P. & van Raalte, D. H., 2020, In : Diabetes Care. 43, 1, p. 228-234 7 p.

Research output: Contribution to journalArticleAcademicpeer-review

Nephroprotective effects of GLP-1 receptor agonists: where do we stand?

Mosterd, C. M., Bjornstad, P. & van Raalte, D. H., 1 Jan 2020, (Accepted/In press) In : Journal of Nephrology.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Oral butyrate does not affect innate immunity and islet autoimmunity in individuals with longstanding type 1 diabetes: a randomised controlled trial

de Groot, P. F., Nikolic, T., Imangaliyev, S., Bekkering, S., Duinkerken, G., Keij, F. M., Herrema, H., Winkelmeijer, M., Kroon, J., Levin, E., Hutten, B., Kemper, E. M., Simsek, S., Levels, J. H. M., van Hoorn, F. A., Bindraban, R., Berkvens, A., Dallinga-Thie, G. M., Davids, M., Holleman, F. & 6 others, Hoekstra, J. B. L., Stroes, E. S. G., Netea, M., van Raalte, D. H., Roep, B. O. & Nieuwdorp, M., 1 Mar 2020, In : Diabetologia. 63, 3, p. 597-610 14 p.

Research output: Contribution to journalArticleAcademicpeer-review

Plasma uric acid and renal haemodynamics in type 2 diabetes patients

Suijk, D. L. S., Smits, M. M., Muskiet, M. H. A., Tonneijck, L., Kramer, M. H. H., Joles, J. A. & van Raalte, D. H., Apr 2020, In : Nephrology (Carlton, Vic.). 25, 4, p. 290-297 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renal hemodynamic effects of sodium-glucose cotransporter 2 inhibitors in hyperfiltering people with type 1 diabetes and people with type 2 diabetes and normal kidney function

van Bommel, E. J. M., Lytvyn, Y., Perkins, B. A., Soleymanlou, N., Fagan, N. M., Koitka-Weber, A., Joles, J. A., Cherney, D. Z. I. & van Raalte, D. H., Apr 2020, In : Kidney International. 97, 4, p. 631-635 5 p.

Research output: Contribution to journalEditorialAcademicpeer-review

Renal sinus fat and renal hemodynamics: a cross-sectional analysis

Spit, K. A., Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Kramer, M. H. H., Joles, J. A., de Boer, A. & van Raalte, D. H., Feb 2020, In : Magnetic Resonance Materials in Physics, Biology and Medicine. 33, 1, p. 73-80 8 p.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renoprotection in diabetic kidney disease: Can incretin-based therapies deliver?

van Baar, M. J. B. & van Raalte, D. H., 2020, In : Current Opinion in Nephrology and Hypertension. 29, 1, p. 103-111 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Sleep and HbA1c in patients with type 2 diabetes: Which sleep characteristics matter most?

Brouwer, A., Van Raalte, D. H., Rutters, F., Elders, P. J. M., Snoek, F. J., Beekman, A. T. F. & Bremmer, M. A., 1 Jan 2020, In : Diabetes Care. 43, 1, p. 235-243 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

The authors reply

van Bommel, E. J. M. & van Raalte, D. H., Apr 2020, In : Kidney International. 97, 4, p. 806 1 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: A post-hoc analysis of a 52-week randomised trial

Muskiet, M. H. A., Bunck, M. C., Heine, R. J., Cornér, A., Yki-Järvinen, H., Eliasson, B., Joles, J. A., Diamant, M., Tonneijck, L. & van Raalte, D. H., 1 Jul 2019, In : Diabetes Research and Clinical Practice. 153, p. 14-22 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Mineralocorticoid Antagonism and Diabetic Kidney Disease

Lytvyn, Y., Godoy, L. C., Scholtes, R. A., van Raalte, D. H. & Cherney, D. Z., 1 Jan 2019, In : Current Diabetes Reports. 19, 1, 4.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

Renal tubular effects of prolonged therapy with the GLP-1 receptor agonist lixisenatide in patients with type 2 diabetes mellitus

Tonneijck, L., Muskiet, M. H. A., Blijdorp, C. J., Smits, M. M., Twisk, J. W., Kramer, M. H. H., Danser, A. H. J., Diamant, M., Joles, J. A., Hoorn, E. J. & van Raalte, D. H., 2019, In : American Journal of Physiology. Renal Physiology. 316, 2, p. F231-F240

Research output: Contribution to journalArticleAcademicpeer-review

SGLT2 inhibitors’ interaction with other renoactive drugs in type 2 diabetes patients: still a lot to learn

van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 2019, In : Kidney International. 96, 2, p. 283-286

Research output: Contribution to journalComment/Letter to the editorAcademic

Sodium glucose cotransporter (SGLT)-2 inhibitors: Do we need them for glucose-lowering, for cardiorenal protection or both?

Scholtes, R. A., van Baar, M. J. B., Lytvyn, Y., Bjornstad, P., Nieuwdorp, M., Cherney, D. Z. I. & van Raalte, D. H., 2019, In : Diabetes, Obesity and Metabolism. 21, S2, p. 24-33

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

The effects of dapagliflozin on cardio-renal risk factors in patients with type 2 diabetes with or without renin-angiotensin system inhibitor treatment: a post hoc analysis

Scholtes, R. A., van Raalte, D. H., Correa-Rotter, R., Toto, R. D., Heerspink, H. J. L., Cain, V., Sjöström, C. D., Sartipy, P. & Stefánsson, B. V., 19 Nov 2019, In : Diabetes, Obesity and Metabolism.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

The impact of sotagliflozin on renal function, albuminuria, blood pressure, and hematocrit in adults with type 1 diabetes

van Raalte, D. H., Bjornstad, P., Persson, F., Powell, D. R., de Cassia Castro, R., Wang, P. S., Liu, M., Heerspink, H. J. L. & Cherney, D., 2019, In : Diabetes Care. 42, 10, p. 1921-1929

Research output: Contribution to journalArticleAcademicpeer-review

The incretin pathway as a therapeutic target in diabetic kidney disease: a clinical focus on GLP-1 receptor agonists

van Baar, M. J. B., van der Aart, A. B., Hoogenberg, K., Joles, J. A., Heerspink, H. J. L. & van Raalte, D. H., 2019, In : Therapeutic Advances in Endocrinology and Metabolism. 10

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access

The New Biology of Diabetic Kidney Disease-Mechanisms and Therapeutic Implications

Lytvyn, Y., Bjornstad, P., van Raalte, D. H., Heerspink, H. L. & Cherney, D. Z. I., 27 Nov 2019, In : Endocrine Reviews. 41, 2, bnz010.

Research output: Contribution to journalReview articleAcademicpeer-review

Open Access
2018

Canagliflozine, een nieuw glucoseverlagend middel

Translated title of the contribution: Canagliflozin, a new glucose-lowering agent: Effect on heart failure in patients with type 2 diabetes mellitusVan Raalte, D. H. & Van Baar, M., 1 Jan 2018, In : Nederlands Tijdschrift voor Geneeskunde. 162, 18, D2755.

Research output: Contribution to journalComment/Letter to the editorProfessional

Depicting the composition of gut microbiota in a population with varied ethnic origins but shared geography

Deschasaux, M. L., Bouter, K. E., Prodan, A., Levin, E., Groen, A. K., Herrema, H., Tremaroli, V., Bakker, G. J., Attaye, I., Pinto-Sietsma, S-J., van Raalte, D. H., Snijder, M. B., Nicolaou, M., Peters, R., Zwinderman, A. H., Bäckhed, F. & Nieuwdorp, M., 2018, In : Nature Medicine. 24, 10, p. 1526-1531

Research output: Contribution to journalComment/Letter to the editorAcademic

Effect of immediate and prolonged GLP-1 receptor agonist administration on uric acid and kidney clearance: Post-hoc analyses of four clinical trials

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Bjornstad, P., Kramer, M. H. H., Diamant, M., Hoorn, E. J., Joles, J. A. & van Raalte, D. H., 2018, In : Diabetes, Obesity and Metabolism. 20, 5, p. 1235-1245

Research output: Contribution to journalArticleAcademicpeer-review

GLP-1 receptor agonists, CKD, and eGFR trajectory

van Baar, M. J. B., van Raalte, D. H. & Muskiet, M. H. A., 2018, In : Lancet diabetes & endocrinology. 6, 10, p. 764-765 2 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Influence of prednisolone on parameters of de novo lipogenesis and indices for stearoyl-CoA- and Δ6- desaturase activity in healthy males: A Post-hoc analysis of a randomized, placebo-controlled, double-blind trial

Pranger, I. G., van Raalte, D. H., Brands, M., Muskiet, M. H. A., Kema, I. P., Serlie, M. J., Diamant, M., Bakker, S. J. L. & Muskiet, F. A. J., 2018, In : Prostaglandins, Leukotrienes and Essential Fatty Acids. 132, p. 8-15

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial

Muskiet, M. H. A., Tonneijck, L., Huang, Y., Liu, M., Saremi, A., Heerspink, H. J. L. & van Raalte, D. H., 2018, In : The Lancet Diabetes and Endocrinology. 6, 11, p. 859-869

Research output: Contribution to journalArticleAcademicpeer-review

Lixisenatide versus insulin glulisine on fasting and postbreakfast systemic hemodynamics in type 2 diabetes mellitus patients

Tonneijck, L., Muskiet, M. H. A., Twisk, J. W., Kramer, M. H. H., Jan Danser, A. H., Joles, J. A., Smits, M. M. & van Raalte, D. H., 2018, In : Hypertension. 72, 2, p. 314-322

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Renal outcomes in CVOTs: keep calm and carry on

Muskiet, M. H. A., van Baar, M. J. B., Scholtes, R. A. & van Raalte, D. H., 1 Sep 2018, In : The Lancet Diabetes and Endocrinology. 6, 9, p. 674-676 3 p.

Research output: Contribution to journalComment/Letter to the editorAcademic

Sodium glucose cotransporter 2 inhibition and renal ischemia: implications for future clinical trials

van Raalte, D. H. & Cherney, D. Z. I., 2018, In : Kidney International. 94, 3, p. 459-462

Research output: Contribution to journalComment/Letter to the editorAcademic

The osteoblast: Linking glucocorticoid-induced osteoporosis and hyperglycaemia? A post-hoc analysis of a randomised clinical trial

van Bommel, E. J. M., de Jongh, R. T., Brands, M., Heijboer, A. C., den Heijer, M., Serlie, M. J. & van Raalte, D. H., Jul 2018, In : Bone. 112, p. 173-176

Research output: Contribution to journalArticleAcademicpeer-review

2017

Acute plasma amylase increase after glucagon-like peptide -1 receptor agonist exenatide administration in Type 2 diabetes

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Diamant, M., Kramer, M. H. H., Cahen, D. L. & van Raalte, D. H., Apr 2017, In : Diabetic Medicine. 34, 4, p. 591-592 2 p.

Research output: Contribution to journalArticleAcademicpeer-review

Distinct fecal and oral microbiota composition in human type 1 diabetes, an observational study

De Groot, P. F., Belzer, C., Aydin, Ö., Levin, E., Levels, J. H., Aalvink, S., Boot, F., Holleman, F., Van Raalte, D. H., Scheithauer, T. P., Simsek, S., Schaap, F. G., Olde Damink, S. W. M., Roep, B. O., Hoekstra, J. B., De Vos, W. M. & Nieuwdorp, M., 1 Dec 2017, In : PLoS ONE. 12, 12, e0188475.

Research output: Contribution to journalArticleAcademicpeer-review

Glomerular hyperfiltration in diabetes: Mechanisms, clinical significance, and treatment

Tonneijck, L., Muskiet, M. H. A., Smits, M. M., Van Bommel, E. J., Heerspink, H. J. L., Van Raalte, D. H. & Joles, J. A., 1 Apr 2017, In : Journal of the American Society of Nephrology. 28, 4, p. 1023-1039 17 p.

Research output: Contribution to journalReview articleAcademicpeer-review

GLP-1 and the kidney: From physiology to pharmacology and outcomes in diabetes

Muskiet, M. H. A., Tonneijck, L., Smits, M. M., Van Baar, M. J. B., Kramer, M. H. H., Hoorn, E. J., Joles, J. A. & Van Raalte, D. H., 1 Oct 2017, In : Nature Reviews Nephrology. 13, 10, p. 605-628 24 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?

van Raalte, D. H. & Verchere, C. B., 1 Sep 2017, In : Diabetes, Obesity and Metabolism. 19, 9, p. 1205-1213 9 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Intestinal Ralstonia pickettii augments glucose intolerance in obesity

Udayappan, S. D., Kovatcheva-Datchary, P., Bakker, G. J., Havik, S. R., Herrema, H., Cani, P. D., Bouter, K. E., Belzer, C., Witjes, J. J., Vrieze, A., De Sonnaville, N., Chaplin, A., Van Raalte, D. H., Aalvink, S., Dallinga-Thie, G. M., Heilig, H. G. H. J., Bergström, G., Van Der Meij, S., Van Wagensveld, B. A., Hoekstra, J. B. L. & 6 others, Holleman, F., Stroes, E. S. G., Groen, A. K., Bäckhed, F., De Vos, W. M. & Nieuwdorp, M., 1 Nov 2017, In : PLoS ONE. 12, 11, e0181693.

Research output: Contribution to journalArticleAcademicpeer-review

Light therapy: Is it safe for the eyes?

Brouwer, A., Nguyen, H. T., Snoek, F. J., van Raalte, D. H., Beekman, A. T. F., Moll, A. C. & Bremmer, M. A., Dec 2017, In : Acta Psychiatrica Scandinavia. p. 534-548 15 p., 136(6).

Research output: Contribution to journalArticleAcademicpeer-review

Liraglutide and renal outcomes in type 2 diabetes

Tonneijck, L., Van Raalte, D. H. & Muskiet, M. H. A., 30 Nov 2017, In : New England Journal of Medicine. 377, 22, p. 2195 1 p.

Research output: Contribution to journalLetterAcademicpeer-review

Pancreatic Effects of Liraglutide or Sitagliptin in Overweight Patients With Type 2 Diabetes: A 12-Week Randomized, Placebo-Controlled Trial

Smits, M. M., Tonneijck, L., Muskiet, M. H. A., Kramer, M. H. H., Pieters-van den Bos, I. C., Vendrik, K. E. W., Hoekstra, T., Bruno, M. J., Diamant, M., van Raalte, D. H. & Cahen, D. L., Mar 2017, In : Diabetes Care. 40, 3, p. 301-308 8 p.

Research output: Contribution to journalArticleAcademicpeer-review